Variables | Full cohort n=49 321 | Men with CHD, fatal and non-fatal n=2156 | Survivors of first CHD (>28 days) n=1923 | Deceased during follow-up*; non-CHD deaths n=54 | Recurrent CHD during follow-up*, fatal and non-fatal n=902 |
---|---|---|---|---|---|
Mean (SD)/N (%) | Mean (SD)/N (%) | Mean (SD)/N (%) | Mean (SD)/N (%) | Mean (SD)/N (%) | |
IQ | 5.38 (2.06) | 4.95 (2.07) | 4.97 (2.07) | 4.30 (1.54) | 4.88 (2.11) |
Early life factors | |||||
Parent's CVD death, age <65 | 4951 (10.0) | 393 (18.2) | 343 (17.8) | 8 (14.8) | 166 (18.4) |
Low socioeconomic position in childhood | 26 898 (54.5) | 1321 (61.3) | 1171 (60.9) | 29 (53.7) | 562 (62.3) |
Factors in adolescence | |||||
BMI | 21.00 (3.19) | 21.6 (3.02) | 21.6 (2.94) | 21.5 (3.32) | 21.8 (3.13) |
Smoking 1–10 cig/day | 15 489 (31.9) | 703 (32.6) | 620 (32.2) | 18 (33.3) | 296 (32.8) |
Smoking >10 cig/day | 12 935 (26.7) | 852 (39.5) | 749 (40.0) | 25 (46.3) | 381 (42.2) |
Risk use of alcohol | 6422 (13.6) | 373 (17.3) | 320 (16.6) | 13 (24.1) | 168 (18.6) |
Systolic blood pressure | 126.1 (11.8) | 127.7 (12.3) | 127.4 (12.0) | 127.9 (12.6) | 127.2 (12.2) |
Factors in adulthood† | |||||
Occupation | |||||
Non-manual | 20 676 (41.9) | 779 (36.1) | 707 (36.8) | 11 (20.4) | 300 (33.3) |
Manual | 17 600 (35.7) | 895 (41.5) | 790 (41.1) | 25 (46.3) | 391 (43.4) |
Self-employed/farmer | 3864 (7.83) | 165 (7.65) | 152 (7.90) | 2 (3.70) | 72 (7.98) |
Unclassified | 5536 (11.2) | 317 (14.7) | 274 (14.3) | 16 (29.6) | 139 (15.4) |
Income‡ | 190.6 (88.0) | 180.4 (80.2) | 183.0 (80.5) | 143.9 (76.5) | 180.6 (79.4) |
Single household | 13 410 (28.1) | 900 (41.7) | 767 (39.9) | 37 (68.5) | 353 (39.1) |
Other diagnoses | |||||
Comorbidity§ | – | 75 (3.48) | 70 (3.64) | 8 (14.8) | 49 (5.43) |
Complications¶ | – | 119 (5.52) | 107 (5.56) | 7 (13.0) | 65 (7.21) |
*Not within 28 days of first CHD.
†Occupation and income in 1990, at age about 40. Single household at the year or preceding year of first CHD event in the samples; single household in 1990 in the full cohort for comparison.
‡In 1000 Swedish kronor/year.
§Diabetes with complications, pulmonary oedema, acute or chronic renal failure, cerebrovascular disease, malignancy and depression.
¶Cardiogenic shock, cardiac dysrhythmias and congestive heart failure.
BMI, body mass index; CHD, coronary heart disease; CVD, cardiovascular diseases.